This inventor holds 38 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Heterocyclic Compounds. Top assignee: Amgen Inc.. Active years: 2004-2018.
Location History:
- Thousand Oaks, CA (US) (2015 - 2017)
- Ventura, CA (US) (2004 - 2018)
Company Filing History:
Years Active: 2004-2018
Areas of Expertise:
Title: Robert Michael Rzasa: Innovator in Pharmaceutical Patents
Introduction
Robert Michael Rzasa, located in Ventura, California, is an accomplished inventor with an impressive portfolio of 38 patents. His work primarily focuses on the development of novel compounds geared towards treating various inflammatory diseases, cancers, and other complex medical conditions.
Latest Patents
Among his latest innovations, Rzasa has developed patents for heterocyclic compounds and their applications in treating general inflammation, arthritis, and various autoimmune diseases. His inventions encompass a range of conditions, including osteoarthritis, inflammatory bowel disorders, and chronic inflammatory conditions, as well as allergic conditions. Notably, Rzasa’s work also addresses cancers associated with p110δ activity, such as different forms of leukemia and solid tumors, including breast cancer. Additionally, he has made significant contributions with unsaturated nitrogen heterocyclic compounds classified as PDE10 inhibitors, which are useful in treating disorders such as Huntington's disease, schizophrenia, and bipolar disorder.
Career Highlights
Robert Michael Rzasa plays a pivotal role at Amgen Inc., a leading biopharmaceutical company dedicated to developing innovative therapies. His extensive experience and contributions in the field of pharmaceutical patents highlight his commitment to advancing healthcare through groundbreaking research and development.
Collaborations
Throughout his career, Rzasa has collaborated with several distinguished professionals, including Jennifer Rebecca Allen and Andreas Reichelt. These partnerships have allowed him to enhance his research and foster an environment of innovation within the pharmaceutical field.
Conclusion
Robert Michael Rzasa is a notable figure in the world of pharmaceuticals, exemplifying the integration of science and innovation to address critical health issues. With his significant number of patents and continued contributions to medical research, Rzasa remains a key player in developing therapies that improve patient outcomes and enhance the quality of life for many individuals.